Literature DB >> 23117252

Discriminating of ATP competitive Src kinase inhibitors and decoys using self-organizing map and support vector machine.

Aixia Yan1, Xiaoying Hu, Kai Wang, Jing Sun.   

Abstract

A data set containing 686 Src kinase inhibitors and 1,941 Src kinase non-binding decoys was collected and used to build two classification models to distinguish inhibitors from decoys. The data set was randomly split into a training set (458 inhibitors and 972 decoys) and a test set (228 inhibitors and 969 decoys). Each molecule was represented by five global molecular descriptors and 18 2D property autocorrelation descriptors calculated using the program ADRIANA.Code. Two machine learning methods, a Kohonen's self-organizing map (SOM) and a support vector machine (SVM), were utilized for the training and classification. For the test set, classification accuracy (ACC) of 99.92% and Matthews correlation coefficient (MCC) of 0.98 were achieved for the SOM model; ACC of 99.33% and MCC of 0.98 were obtained for the SVM model. Some molecular properties, such as molecular weight, number of atoms in a molecule, hydrogen bond properties, polarizabilities, electronegativities, and hydrophobicities, were found to be important for the inhibition of Src kinase.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117252     DOI: 10.1007/s11030-012-9411-0

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  25 in total

Review 1.  SH2 and SH3 domains as targets for anti-proliferative agents.

Authors:  M Vidal; V Gigoux; C Garbay
Journal:  Crit Rev Oncol Hematol       Date:  2001-11       Impact factor: 6.312

2.  Comparison of the predicted and observed secondary structure of T4 phage lysozyme.

Authors:  B W Matthews
Journal:  Biochim Biophys Acta       Date:  1975-10-20

3.  Discovery and preliminary structure-activity relationship studies of novel benzotriazine based compounds as Src inhibitors.

Authors:  Glenn Noronha; Kathy Barrett; Jianguo Cao; Elena Dneprovskaia; Richard Fine; Xianchang Gong; Colleen Gritzen; John Hood; Xinshan Kang; Boris Klebansky; G Li; W Liao; Dan Lohse; Chi Ching Mak; Andrew McPherson; Moorthy S S Palanki; Ved P Pathak; Joel Renick; Richard Soll; Ute Splittgerber; Wolfgang Wrasidlo; Binqi Zeng; Ningning Zhao; Y Zhou
Journal:  Bioorg Med Chem Lett       Date:  2006-08-22       Impact factor: 2.823

Review 4.  Of molecules and humans.

Authors:  Johann Gasteiger
Journal:  J Med Chem       Date:  2006-11-02       Impact factor: 7.446

5.  Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors.

Authors:  Diane H Boschelli; Daniel Wang; Yan Wang; Biqi Wu; Erick E Honores; Ana Carolina Barrios Sosa; Inder Chaudhary; Jennifer Golas; Judy Lucas; Frank Boschelli
Journal:  Bioorg Med Chem Lett       Date:  2010-03-07       Impact factor: 2.823

6.  N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor.

Authors:  Laurent F Hennequin; Jack Allen; Jason Breed; Jon Curwen; Michael Fennell; Tim P Green; Christine Lambert-van der Brempt; Rémy Morgentin; Richard A Norman; Annie Olivier; Ludovic Otterbein; Patrick A Plé; Nicolas Warin; Gerard Costello
Journal:  J Med Chem       Date:  2006-11-02       Impact factor: 7.446

7.  Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase.

Authors:  Huiping Guan; A Douglas Laird; Robert A Blake; Cho Tang; Chris Liang
Journal:  Bioorg Med Chem Lett       Date:  2004-01-05       Impact factor: 2.823

8.  Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases.

Authors:  Yihan Wang; Chester A Metcalf; William C Shakespeare; Raji Sundaramoorthi; Terence P Keenan; Regine S Bohacek; Marie Rose van Schravendijk; Shiela M Violette; Surinder S Narula; David C Dalgarno; Chad Haraldson; Jeffrey Keats; Shuenn Liou; Ukti Mani; Selvi Pradeepan; Mary Ram; Susan Adams; Manfred Weigele; Tomi K Sawyer
Journal:  Bioorg Med Chem Lett       Date:  2003-09-15       Impact factor: 2.823

9.  Inhibition of Src kinase activity by 4-anilino-5,10-dihydro-pyrimido[4,5-b]quinolines.

Authors:  Diane H Boschelli; Dennis Powell; Jennifer M Golas; Frank Boschelli
Journal:  Bioorg Med Chem Lett       Date:  2003-09-15       Impact factor: 2.823

10.  Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.

Authors:  Cristina Tintori; Matteo Magnani; Silvia Schenone; Maurizio Botta
Journal:  Eur J Med Chem       Date:  2008-07-11       Impact factor: 6.514

View more
  3 in total

1.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

2.  ChemStable: a web server for rule-embedded naïve Bayesian learning approach to predict compound stability.

Authors:  Zhihong Liu; Minghao Zheng; Xin Yan; Qiong Gu; Johann Gasteiger; Johan Tijhuis; Peter Maas; Jiabo Li; Jun Xu
Journal:  J Comput Aided Mol Des       Date:  2014-07-17       Impact factor: 3.686

3.  Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach.

Authors:  Kanupriya Mahajan; Himanshu Verma; Shalki Choudhary; Baddipadige Raju; Om Silakari
Journal:  Mol Divers       Date:  2021-07-16       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.